A flow cytometric assay for the quantification of MSC lysis by peripheral blood mononucleated cells
Mesenchymal stromal cells (MSC) are attractive candidates for the treatment of acute graft versus host disease (aGvHD) or autoimmune disorders. However, mechanisms of MSC recognition remain unclear and there are evidences that MSC are not totally immunoprivileged. Data suggest that MSC undergo apopt...
Main Authors: | Katia Chieregato, Martina Bernardi, Alberta Alghisi, Rosaria Giordano, Lorenza Lazzari, Omar Perbellini, Mario Rassu, Marco Ruggeri, Giuseppe Astori |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844021001419 |
Similar Items
-
Novel insights into MSC-EVs therapy for immune diseases
by: Peilong Lai, et al.
Published: (2019-03-01) -
Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness
by: Lambros Kordelas, et al.
Published: (2019-04-01) -
The Study of Correlation between Different Complete Blood Count Parameters in Acute Coronary Syndromes
by: Abhey Chawla, et al.
Published: (2019-10-01) -
High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sources
by: Eliana Amati, et al.
Published: (2018-01-01) -
Haematological Predictors of Section Recovery in Dengue Cases
by: Sushma Nayar, et al.
Published: (2019-10-01)